New booster study shows promise for broader COVID protection
NCT ID NCT05542862
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 25 times
Summary
This study tested a single booster dose of the SpikoGen vaccine in 81 adults who had already received a full course of any COVID-19 vaccine at least 3 months earlier. The goal was to see if SpikoGen could safely boost the immune system's ability to fight the virus, regardless of which vaccine people had first. Researchers measured antibody levels and tracked any side effects or infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ARASMI
Adelaide, South Australia, 5042, Australia
Conditions
Explore the condition pages connected to this study.